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Abstract
Background: People with low back pain (LBP) in the community often do not receive evidence-based advice and management.
Community pharmacists can play an important role in supporting people with LBP as pharmacists are easily accessible to provide
first-line care. However, previous research suggests that pharmacists may not consistently deliver advice that is concordant with
guideline recommendations and may demonstrate difficulty determining which patients require prompt medical review. A clinical
decision support system (CDSS) may enhance first-line care of LBP, but none exists to support the community pharmacist–client
consultation.
Objective: This study aimed to develop a CDSS to guide first-line care of LBP in the community pharmacy setting and to
evaluate the pharmacist-reported usability and acceptance of the prototype system.
Methods: A cross-platform Web app for the Apple iPad was developed in conjunction with academic and clinical experts using
an iterative user-centered design process during interface design, clinical reasoning, program development, and evaluation. The
CDSS was evaluated via one-to-one user-testing with 5 community pharmacists (5 case vignettes each). Data were collected via
video recording, screen capture, survey instrument (system usability scale), and direct observation.
Results: Pharmacists’ agreement with CDSS-generated self-care recommendations was 90% (18/20), with medicines
recommendations was 100% (25/25), and with referral advice was 88% (22/25; total 70 recommendations). Pharmacists expressed
uncertainty when screening for serious pathology in 40% (10/25) of cases. Pharmacists requested more direction from the CDSS
in relation to automated prompts for user input and page navigation. Overall system usability was rated as excellent (mean score
92/100, SD 6.5; 90th percentile compared with similar systems), with acceptance rated as good to excellent.
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Conclusions: A novel CDSS (high-fidelity prototype) to enhance pharmacist care of LBP was developed, underpinned by
clinical practice guidelines and informed by a multidisciplinary team of experts. User-testing revealed a high level of usability
and acceptance of the prototype system, with suggestions to improve interface prompts and information delivery. The small study
sample limits the generalizability of the findings but offers important insights to inform the next stage of system development.
(JMIR Med Inform 2020;8(5):e17203) doi: 10.2196/17203
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Introduction
Background
Low back pain (LBP) is a major cause of disability worldwide
[1], with almost 1 in 5 people reporting LBP at any one time
[2]. People with LBP typically consult general practice, allied
health, or community pharmacy for advice and management
[3,4]. The role of community pharmacists has evolved from
dispensing medication and providing medication advice, to
include screening and management for a range of health
conditions such as minor ailments and chronic health conditions
[5-10]. In alignment with this expanding service model, there
is interest for community pharmacy to play a greater role in the
early management of back pain [11-13]. There are also potential
economic benefits for using community pharmacy as an access
point for a range of services, with lower patient and health
system costs compared with other primary care models [13-15].
Evidence-Practice Gaps in Management of Low Back
Pain
Current clinical practice guidelines for the management of LBP
recommend first-line care that includes reassurance, advice to
stay active and avoid bed rest, and discouraging diagnostic
imaging such as plain radiographs unless serious pathology is
suspected [3,16]. Despite these guideline recommendations, a
substantial gap between evidence and practice still exists [17].
For example, Abdel Shaheed et al [18] reported that community
pharmacists and their staff were able to deliver adequate advice
on medication use for LBP, but their ability to provide advice
on nonpharmacological management such as staying active,
avoiding bed rest, and discouraging imaging was inconsistently
delivered. The ability to identify presentations that required
prompt medical review was also limited for some community
pharmacists.
Support for the Community Pharmacist
Clinical decision support systems (CDSSs) are targeted
electronic systems that link evidence-based recommendations
with the clinical presentation of the individual to improve
clinical decision making and support patient engagement with
health decisions [19-24]. Recently, CDSSs have been
implemented for management of noncancer pain in the primary
care setting [25-29], but these do not transfer to the pharmacy
setting because of differences in professional training and
consultation environment. Pharmacists already have access to
CDSSs (eg, management of infection and deprescribing) [30,31],
but none exist to support the community pharmacist–client
consultation for LBP. Therefore, a CDSS for the early
management of LBP in community pharmacy is warranted [32].
The main objective of this study was to develop a CDSS for
pharmacists to guide first-line care of LBP in the community
pharmacy setting using a mobile data collection system (Apple
iPad, Apple Inc). We also sought to evaluate the
pharmacist-reported usability and acceptance of the high-fidelity
prototype to inform the next stage of CDSS development.
Methods
Overview
This study describes the iterative development of a CDSS for
the management of pharmacy clients with LBP in community
pharmacy. The CDSS was developed by a multidisciplinary
team that included two pharmacy academics, a human-computer
interaction expert, and four content experts in LBP [33]. Team
members were consulted during each stage of development.
The CDSS (high-fidelity prototype) was evaluated via a
small-scale usability study [34]. The study was approved by
University of Sydney Human Research Ethics Committee
(2017/027).
User-Centered Design Framework
Development of the CDSS was underpinned by the framework
for user-centered design and evaluation of prototypes for clinical
information systems (Figure 1) [35]. The framework describes
the evolution of a CDSS based around low-cost usability testing
methods before future evaluation with real clients in a clinical
practice setting. During initial design of the CDSS, input was
sought from a range of people involved with community
pharmacy, including two pharmacy academic/educators, a
community pharmacist, and an industry representative. This
approach sought to uncover pharmacist training and procedural
constraints that may impact pharmacist decision making for
LBP [36], given that a pathway for the contemporary
management of LBP specific to the community pharmacy setting
does not exist.
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Figure 1. Clinical decision support system development based on prototyping and iterative testing (modified from Kushniruk et al). This study is
represented by shading. CDSS: clinical decision support system.
Architectural Design, Analysis, and Refinement
Design goals were informed by Bates et al [37], Khorasani et
al [38], and Zikos et al [39] who described features of a decision
support system necessary to facilitate integration into clinical
practice. The design goals of this CDSS were to (1) support
pharmacists to offer simple, clear evidence-based advice to the
pharmacy client who presents with LBP; (2) integrate with the
pharmacist workflow (eg, consideration of medicines during
decision making); (3) maximize time efficiency; and (4) provide
a personalized report of recommendations for the pharmacy
client.
The CDSS was designed in three components [22]: (1)
knowledge base, (2) reasoning engine, and (3) interface (see
Multimedia Appendix 1 for further explanation of design
process). Briefly, the knowledge base included high level advice
for the screening of serious pathology and early management
of LBP [3,40-49]. The reasoning engine was coded from the
knowledge base then refined using experts in LBP and
community pharmacy to consider age, sex, results of screening
questions, pain history, and up to three current medicines for
LBP (Multimedia Appendix 2). Recommendations for the
pharmacist are separated into key messaging for the pharmacy
client, suggested medicine use, and referral options. The
pharmacist progresses from a landing page (Figure 2), through
to history, screening, and advice pages (Multimedia Appendix
3). Data input is via a touch interface (checkboxes, drop-down
menus, and free-text input). The pharmacist can accept, modify,
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or reject advice generated by the CDSS. Finally, a custom letter
for the pharmacy client is generated based on the pharmacist’s
final recommendation (Multimedia Appendix 4).
The multidisciplinary team of experts were engaged at each
stage of design, development, and internal testing. Decision
trees were iteratively modified before coding decision logic and
programming of the interface (Ionic Framework), then refined
through multiple (>10) test cycles. Once the logic and interface
were complete, each of the 408 unique decision combinations
were checked for accuracy using the Web interface. Similarly,
each of the clinical case vignettes (and CDSS-generated client
handouts) were tested by the research team for language and
accuracy before the interview phase.
Figure 2. Clinical decision support system landing page showing clinical flow and scope of key messages. Tapping anywhere on this screen moves to
the “clinical history” page.
Usability Testing
After the completion of the internal testing, the next phase of
usability was based on the recommendations of Yen and Bakken
[34], where the community pharmacist interacted with the CDSS
through a series of 5 case vignettes (system-user-task).
Participants
In all, 5 practising community pharmacists (with 5-27 years of
clinical experience), not involved in the initial development
phase, from 5 different community pharmacies in the Sydney
metropolitan area were each presented with 5 case vignettes
during a one-to-one interview. Inclusion criteria required
pharmacists to have experience with computer use within
pharmacy (eg, computer-based dispensing systems) and be
comfortable with tablet computer use (eg, internet browsing).
Previous studies suggest that with 5 participants, up to 80% of
usability issues can be identified (including up to 100% of major
usability issues) when a system is designed for a specific group
of users [50,51].
Interview Procedure and Training
Each pharmacist was presented with the same 5 case vignettes
role-played by the lead researcher (AD). Clinical scenarios
included presentations of both nonserious and serious causes
of LBP in adult and elderly populations. Cases 1 and 2 involved
nonserious LBP, case 3 involved suspicion of an osteoporotic
compression fracture, case 4 presented with nonserious low
back and leg pain below the knee, and case 5 presented with
LBP and a recent history of cancer (Multimedia Appendix 5).
The interviews were held in a location convenient to the
pharmacist, usually in the designated clinical consultation space
within the pharmacy. The pharmacist was required to interact
with both the “client” (researcher) and the CDSS on an iPad
Air (iOS 12.4, Apple Inc). Before beginning the case vignettes,
the pharmacist was trained in the operation of the CDSS via
interface “walk through.” Training also included a brief
summary of the evidence underpinning the CDSS, explanation
of the pharmacist-client interview process, and how to accept
or reject the decision support offered by the CDSS.
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The interview was conducted using a think-aloud protocol and
employed an active intervention approach [52]. That is, the
pharmacist was allowed to ask questions of the researcher during
interaction with the “client.” Active intervention by the
researcher was triggered when the pharmacist was unable to
progress through the CDSS, sought clarification when
interacting with the interface, or had questions at completion
of the case (eg, reflecting upon management decisions generated
by the CDSS). All instances of active intervention were logged
and evaluated.
Data Collection
Four modes of data collection were used during the interview:
(1) think-aloud protocols [53,54] with active intervention
approach [52], (2) video/audio recording and screen capture
during interaction with the iPad [55,56], (3) direct interview
questions at the completion of interaction with the CDSS
[26,57], and (4) completion of a survey instrument (system
usability scale) [58,59]. The survey instrument was completed
by the pharmacist at the end of the interview and without the
researcher present (Multimedia Appendix 5).
Evaluation
Evaluation of Usability Testing
Interviews were transcribed verbatim, then independently
analyzed by two researchers with assistance by a third (AD, CS
and AK) using a directed content analysis methodology, where
key concepts from existing usability studies of health
information technology methodology were used to inform initial
coding categories [34]. Operational definitions for each category
were determined based on the specific goals of the CDSS. Any
redundant coding categories were collapsed. The analysis of
pharmacist sentiment was categorized as “negative,” “neutral,”
or “positive” in consultation with the research team [60].
Frequency of responses were tabulated first by category, then
by sentiment (NVivo 12.5, QSR International). Interaction with
the iPad was time-stamped to calculate duration spent on each
page of the iPad, periods of pharmacist hesitation, and page
navigation decisions. Responses to survey instruments were
described, and a system usability scale was scored [61].
Level of Acceptance of Clinical Reasoning and Decision
Support
At the completion of all case vignettes, each pharmacist was
shown an overview of the clinical reasoning engine and then
asked to reflect on the logic that informed the recommendation
for each case. To quantify the level of acceptance for the core
set of recommendations generated by the CDSS (self-care
advice, medicines advice, and referral advice), the pharmacist’s
acceptance (accept/not accept) was logged. Additional advice
offered by the pharmacist relating to clinical management was
entered in free-text fields on the iPad.
Results
Pharmacist Interview
All pharmacists completed 5 case vignettes on the Apple iPad.
Pharmacists were exposed to cases in the same order. The total
time taken to role-play all 5 case vignettes (excluding discussion
on decision logic or system improvements) ranged from 14 min
35 seconds (Pharmacist #1) to 28 min 4 seconds (Pharmacist
#2). Case vignettes that included nonserious LBP required less
time (Cases 1 and 2: mean 3 min 40 seconds per case, SD 1 min
8 seconds) than cases that raised suspicion of serious causes of
LBP (Cases 3-5: mean 4 min 46 seconds per case, SD 1 min 23
seconds).
Evaluation of Usability Testing
Coding Categories
A total of 162 statements during the 25 interactions between
pharmacists and “clients” were logged. Nine coding categories
were identified using directed content analysis (Ease-of-use,
Consistency, Visibility, Navigation, Workflow, Content,
Understandability, Clarity, and Acceptance). For final coding,
the categories Navigation and Workflow were merged, and
Understandability was defined under Clarity, which resulted
in seven final categories. Statements were also coded by
sentiment (negative, neutral, or positive). Table 1 describes each
category, with statement frequency and representative examples.
A total of 71 statements related to the CDSS interface, and 91
statements related to clinical information (content) provided by
the CDSS.
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Table 1. Coding categories with statement frequency and representative examples.
Representative coded statements with sentimentSentiment frequencyCoding category with subcategory
TotaldPositivecNeutralbNegativea
Interface
267316Ease-of-use: commentary on the sim-
plicity of operation of the CDSSe
• Negative: (SCREENING page) “It would be a
lot easier if it said, ‘I’ve just got some questions
I want to ask you, and I just go through them
regardless of what you told me.” (Pharmacist
#5)
• Positive: “The App has simple language, it’s
not complicated, not medical, so that it can be
used by everyone. So that’s a good thing.”
(Pharmacist #1)
13472Consistency: commentary on the con-
sistency of visual language or interac-
tion model
• Negative: “I’m pretty sure I did tick ‘history of
malignancy’. I was surprised that when I ticked
that it didn’t do what it did do with Betty.”
(Pharmacist #5)
• Positive: (Reads letter) “OK, so it’s very similar
to the others.” (Pharmacist #3)
16367Visibility: commentary on the visibility
of system capabilities and system status
and navigational cues within the CDSS
• Negative: (ADVICE page) “I didn’t notice this
one. (points to medicine advice)” (Pharmacist
#4)
• Positive: “The prompts are there, so it’s just
something to get used to maneuvering... which
isn’t very difficult because its laid out quite
easily/quite nicely.” (Pharmacist #2)
162122Navigation/workflow: observation and
commentary on progression/sequence
through the CDSS
• Negative: “If we miss one of these pieces of
information, does the App ask us to go back?”
(Pharmacist #1)
• Positive: (HISTORY page) “I really liked this
page. I think it’s easy to go through.” (Pharma-
cist #3)
Clinical information
271296Content: commentary on what informa-
tion is/is not provided by the CDSS
• Negative: (HISTORY page) “Maybe we could
add another icon: ‘Pregnant or Breastfeeding’”
(Pharmacist #4)
• Positive: (ADVICE page) “OK, so it actually
knows it’s sub-therapeutic when I put sub-ther-
apeutic input. That’s very good. That’s very
good.” (Pharmacist #2)
15591Clarity: commentary on the clarity of
the information provided by the CDSS
• Negative: (SCREENING page) “I know that
it’s not an infection because they say, ‘I fell,
and now I’ve got pain’, so it seems like I proba-
bly of shouldn't have asked the questions, but I
still did because it was still there.” (Pharmacist
#5)
• Positive: (MEDICINES page) “...to recommend
Ibuprofen or Aspirin or whatever, then the dose
that’s required. That’s really good. That’s really
good.” (Pharmacist #1)
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Representative coded statements with sentimentSentiment frequencyCoding category with subcategory
TotaldPositivecNeutralbNegativea
• Negative: (ADVICE page) “I’m not sure about
‘stay active’. I’m not sure it’s OK.” (Pharmacist
#1)
• Negative: (ADVICE page) “..and she needs to
see someone – like a specialist in this area to
find out what is the reason – it is good to have
an X-Ray.” (Pharmacist #4)
• Positive: (Reads letter) “OK. So, stay active.
That’s really good.” (Pharmacist #2)
• Positive: (regarding use in practice) “I’d love
it... I like the clinical part of my job. I was
thinking of having something on pain manage-
ment plans.” (Pharmacist #1)
493496Acceptance: commentary on the clini-
cal value of the CDSS recommenda-
tions
aNegative: negative sentiment.
bNeutral: neutral sentiment.
cPositive: positive sentiment.
dTotal: total sentiment count for subcategory.
eCDSS: clinical decision support system.
Pharmacists’Statements Related to Interaction With the
Interface
The categories Ease-of-use and Visibility together accounted
for 59% (42/71) of statements about the interface with a positive
to negative comment ratio of 0.4 (7:16) and 0.4 (3:7),
respectively. The majority of statements with negative sentiment
involved interaction with the screening page (10/27 statements,
Figure 3). The remainder scored with negative sentiment
included comments on layout (eg, button position inconsistent)
or visibility issues (eg, text size too small).
For example, statements with negative sentiment reported during
interaction with the screening page included:
I find this part a bit long. I’m always reading through
it (risk of spinal inflammation) … maybe it’s just me.
Maybe I should just read it properly. [Pharmacist #2]
[reads from iPad] Leg pain with altered sensation or
weakness. So, I guess I didn’t see that part... is there
a reason that that’s here (points to the 2nd column)
– Oh, because it’s not a clinical history, yep.
[Pharmacist #3]
It’s just like you are trying to focus on the patient, so
you are trying to do two things at once. If the patient
was happy for me to pause, ‘cause you feel a bit
awkward, just processing this whilst the patient is in
front of you. [Pharmacist #4]
I think that with this (SCREENING PAGE) is probably
the hardest screen here because, like some of the
questions I knew, like all of the cases so far, I know
that it’s not an infection because they say I fell and
now I’ve got pain, so it seems like I probably of
shouldn’t have asked the questions. [Pharmacist #5]
Statements with positive sentiment for the interface referenced
the simplicity of layout, navigation, and language used (5/16
statements). In addition, statements with positive sentiment
were made regarding integration with the pharmacist’s workflow
(5/16 statements). Pharmacists’ statements relating to the
operation of the CDSS (eg, “so I just press here,” and “then it
comes out of the printer?”) comprised the majority scored with
neutral sentiment (17/28 statements). Queries related to the
operation of the CDSS decreased in frequency as each interview
progressed.
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Figure 3. Clinical decision support system screening page for raising suspicion of a serious cause of low back pain. The “No” response is the default
state.
Pharmacists’Statements Related to Clinical Information
The categories Content and Acceptance together accounted for
84% (76/91) of statements related to clinical information
provided by the CDSS, with a positive to negative comment
ratio of 2.0 (12:6) and 5.7 (34:6), respectively. The remainder
of statements related to Clarity of the clinical information
provided by the CDSS. Statements with negative sentiment for
Content (6/27 statements) included request for items absent
from history (eg, pharmacists wanted to record current level of
pain, whether pregnant or breastfeeding, and history of ulcer).
Statements with negative sentiment for Acceptance (6/49
statements) included disagreement with, or questioning of,
CDSS-generated advice in the categories self-care, medicines,
and referral advice. For example:
Yes, but we always need to do further investigations
to find out… and she needs to see someone – like a
specialist in this area to find out what is the reason
– it is good to have an X-Ray. [Pharmacist #4; case
1: nonserious cause of LBP]
In my practice, a typical customer that you have just
described will usually be on some kind of blood
pressure medication – usually – which is why we
always tend to recommend paracetamol first.
[Pharmacist #5; case 2: recommendation to begin
NSAID therapy]
But, from the other point of view, would that narrow
the amount of medicine that we recommend? So, from
the business-Pharm point of view, would that exclude
a lot of products? [Pharmacist #1; general comment
at end of interview]
Statements with positive sentiment for Content (12/27
statements) included what pharmacists considered to be the
right information displayed at the right time. For example:
This is what's really interesting, is what really gives
this one the meaning – I like the logic behind it.
[Pharmacist #1; reacting to decision for suspicion of
fracture]
Yes, we do need to know this. [Pharmacist #4; points
to increased risk of cancer]
OK, so it actually knows it’s sub-therapeutic when I
put sub-therapeutic input. That’s very good. That’s
very good. [Pharmacist #5]
Statements with positive sentiment for Acceptance (34/49
statements) included commentary on the clinical value of
information generated by the CDSS in areas of self-care,
medicines advice, and referral advice. These statements broadly
reflected agreement with advice generated by the CDSS. For
example:
Most of the time it was very logical, it was very
rational and logical… It leads us to the right decision.
[Pharmacist #1]
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Definitely! Its prompting you to ask questions. I must
admit some of those questions we probably don’t
always ask, but we need to be asking... [Pharmacist
#2]
OK, so just add on (stay active) Yep. OK. Instead of
just seeing the GP straight away. OK. Cool!
[Pharmacist #3; during the selection of self-care
advice]
We excluded some diseases which is good. I found
out that she is not taking enough medicine.
[Pharmacist #4]
Yes, so I would say: using a heat wrap will also help,
and I would say take the Voltaren 2-3 times per day
with food – yes, it says this already! [Pharmacist #5]
Similar to pharmacists’ questions relating to the interface,
comments/questions related to clarification of CDSS-generated
advice were scored with neutral sentiment. This type of question
also decreased in frequency as each pharmacist moved through
the 5 cases.
System Usability Scale
The system usability scale [59,61] was administered to each
participant at the completion of the interview without the
researcher present. Individual usability scores ranged from 82.5
out of 100 to 100 out of 100, which were interpreted as good
to excellent usability, respectively [59]. The overall usability
score was rated as excellent (mean score 92 out of 100, SD 6.5;
90th percentile compared with similar systems).
Level of Acceptance of Clinical Reasoning and Decision
Support
Across the 5 case vignettes, 70 recommendations were generated
by the CDSS related to self-care advice, medicine advice, and
referral advice. Pharmacists accepted 90% (18/20) of self-care
recommendations, 100% (25/25) of medicines recommendations,
and 88% (22/25) of referral recommendations. Of those
accepted, pharmacists added to the advice for 8% (5/65) of the
recommendations generated by the CDSS (eg, Figure 4).
Figure 4. Advice page showing the pharmacist #1 acceptance of self-care advice, the augmentation of medicine advice by the pharmacist (“Also, ADD
PHYSIO CREAM as required”), and the acceptance of referral advice (green arrows and green text box).
Discussion
Principal Findings
A CDSS was developed to enhance pharmacist care of LBP,
underpinned by clinical practice guidelines and informed by a
multidisciplinary team of experts that included consultation
with community pharmacy. Community pharmacists rated the
overall usability of the high-fidelity protype as good to excellent
[59], despite expression of some negative sentiment in relation
to guidance in screening for serious causes of LBP and interface
inconsistency. There was a high level of acceptance for the
advice generated by the CDSS for self-care, medicines, and
referral, with pharmacists augmenting advice for a minority
(5/65) of recommendations.
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Usability
Pharmacists reported a high level of usability based around
simple use of language, logical workflow, brief consultation
time, ability to customize advice, and convenience of a
customized handout for the client. A number of usability issues
were raised with regard to interface including page layout, text
size, and button placement, which will be considered in the next
phase of the CDSS refinement. The screening page (Figure 3)
received the majority of negative comments and may reflect
nonintuitive interaction with the layout of the screening page
and/or lack of familiarity with the screening questions used to
raise suspicion of serious causes of LBP. Although education
for pharmacists in Australia contains topics on symptom
recognition for differential diagnosis [62] and interprofessional
referral [63], pharmacists expressed interest for more training
on this topic, which is consistent with recommendations of
Abdel Shaheed et al [64].
Acceptance of the Clinical Support Provided by the
Clinical Decision Support System
All pharmacists agreed that the information provided by the
CDSS was applicable to the clinical scenarios presented and
could potentially improve client-pharmacist encounters. One
pharmacist disagreed with the messaging to avoid imaging and
preferred to refer to medical care as a first option for nonserious
LBP, but given the small sample, may not be representative of
their peers. Pharmacists also commented that the CDSS helped
them to ask more questions of the client with LBP and increased
management options for LBP beyond their usual advice.
However, it is unclear if the advice delivered by the CDSS in
this setting would be superior to usual pharmacy care for LBP.
Guidance for Pain Management in Community
Pharmacy
Pharmacists commented that they appreciated guidance provided
by the CDSS in relation to management, particularly for options
beyond medicines advice. This aligns with recommendations
of Abdel Shaheed et al [65] and others [11] on the potential
benefit of tools/guidelines to support pharmacists when
managing clients with LBP. Pharmacists also reflected on the
current general lack of guidance to manage pain within
pharmacy compared with the promotion and availability of
management tools for other health conditions [5,7,8,14,66].
This view is consistent with results from a recent study by Abdel
Shaheed et al [65] who found that pharmacists were receptive
to implementing a disease state management program for LBP.
One area highlighted by pharmacists was the lack of operational
knowledge in relation to screening clients for serious causes of
LBP, which has been highlighted previously [18]. Abdel
Shaheed et al also found that pharmacists had both the
willingness and capacity to increase knowledge in this area
[32,64]. One goal of a training module integrated into the next
version of the CDSS would be to empower the pharmacist with
the skillset to raise suspicion of potentially serious underlying
pathology, then inform clients of options for prompt medical
review [43,45].
Limitations
The small sample size may not be adequate to capture the full
range of pharmacists’views or usability issues thus limiting the
generalizability of the results [67], particularly with regard to
the level of acceptance. However, the sample size was
appropriate for this stage of CDSS development [34,51]. That
is, it was sufficient to identify major usability issues (eg, when
screening for risk of serious disease), that the CDSS interface
could be navigated with minimal training, and that decisions
generated were logical and easy for the pharmacist to apply (in
a simulated scenario). The method used to assess usability (think
aloud with active intervention) may have enhanced task
performance through researcher-induced bias [68] but allowed
greater insight into the sections of the CDSS that required further
development [52]. Another source of bias that may have
enhanced task performance was the nonrandomized order of
cases (case complexity was greater later in interview). This
stage of CDSS development was to finalize design elements in
the community pharmacy setting before testing with real clients
[34]. In its current design, the CDSS does not integrate with
existing electronic record systems in pharmacy, which would
be necessary before advanced testing and would increase the
chance of adoption by pharmacists [69]. One approach would
be integration with existing disease state management systems
[70], which was also suggested by pharmacists during testing.
Comparison With Prior Work
This CDSS is the first tool that the authors are aware of to assist
community pharmacists in first-line care for people with LBP.
Other electronic decision support systems have been targeted
at the primary care setting for the management of LBP [25] and
chronic pain [26,27]. This CDSS differs from existing systems
in that it aims to empower the pharmacist to offer
evidence-based first-line care beyond medicines advice, and
stepped referral options to allied health, primary, or emergency
care based on presentation or symptom progression. The
opportunity to enhance the pharmacist-client interaction,
identified as lacking in other systems [27,71], has been built
into this CDSS by allowing the pharmacist to modify
management advice then provide a customized handout for the
client.
Future Direction
The next phase is to modify the CDSS with lessons learned
from this usability study, then reevaluate during the next level
of system development (integration with clients into the
pharmacy setting) [34]. The CDSS will also be evaluated with
respect to the credibility of advice and satisfaction with care
from the perspective of clients with LBP. An education module
on the evidence-based management of LBP could be delivered
to pharmacists in conjunction with training for the CDSS, which
would assist with knowledge of screening for pathology and
give context to the guideline-based care options suggested by
the CDSS. Future studies may establish if pharmacist training
during the use of a CDSS within the clinical encounter improves
both pharmacist and pharmacy client satisfaction with care.
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Conclusions
Despite many years of clinical guidelines for the management
of LBP, significant evidence-to-practice gaps remain. This
CDSS has been designed to provide a unique opportunity for
community pharmacists to provide simple evidence-based advice
for clients who present with LBP. Importantly the CDSS offers
key messages of reassurance, to remain active, to use medicines
appropriately, and to avoid inappropriate imaging.
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